Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2006; 12(9): 1356-1361
Published online Mar 7, 2006. doi: 10.3748/wjg.v12.i9.1356
Published online Mar 7, 2006. doi: 10.3748/wjg.v12.i9.1356
Table 2 Influence of preoperative chemotherapy on expression of Fas/FasL, PD-ECGF and AI, PI
| Group N | Fas | FasL | PI | AI | PD-ECGF + - |
| + - | + - | (%) | (%) | ||
| 5’-DFUR 18 | 12 6 | 9 9 | 40.51 ± 12.62 | 14.39 ± 9.49 | 4 14 |
| CF+5-FU 16 | 7 9 | 13 3 | 41.12 ± 15.26 | 14.11 ± 9.68 | 9 7 |
| Control 20 | 9 11 | 17 3 | 58.33 ± 15.69 | 6.88 ± 7.37 | 13 7 |
| X2/F value | 2.379 | 6.708 | 9.083 | 4.409 | 7.542 |
| P value | 0.304 | 0.035 | 0 | 0.017 | 0.023 |
- Citation: Zhao WH, Wang SF, Ding W, Sheng JM, Ma ZM, Teng LS, Wang M, Wu FS, Luo B. Apoptosis induced by preoperative oral 5’-DFUR administration in gastric adenocarcinoma and its mechanism of action. World J Gastroenterol 2006; 12(9): 1356-1361
- URL: https://www.wjgnet.com/1007-9327/full/v12/i9/1356.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i9.1356